Managing the Dual Diagnosis Dilemma of Bipolar Disorder and Substance Abuse in Clinical Settings

References

• Akiskal, H. S., & Pinto, O. (1999). The evolving bipolar spectrum: Prototypes I, II, III, and IV. The Psychiatric Clinics of North America, 22(3), 517–534, vii. https://doi.org/10.1016/S0193-953X(05)70093-9
   PubMed Web of Science ®Google Scholar
• Amin-Esmaeili, M., Motevalian, A., Rahimi-Movaghar, A., Hajebi, A., Sharifi, V., Mojtabai, R., & Gudarzi, S. S. (2018). Bipolar features in major depressive disorder: Results from the Iranian mental health survey (IranMHS). Journal of Affective Disorders, 241, 319–324. https://doi.org/10.1016/J.JAD.2018.08.014
   PubMed Web of Science ®Google Scholar
• Arnaudo, C. L., Andraka-Christou, B., & Allgood, K. (2017). Psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment. Current Addiction Reports, 4(1), 1–13. https://doi.org/10.1007/s40429-017-0132-4
   PubMedGoogle Scholar
• Bae, S. O., Kim, M. D., Lee, J. G., Seo, J.-S., Won, S.-H., Woo, Y. S., Seok, J.-H., Kim, W., Kim, S. J., Min, K. J., Jon, D.-I., Shin, Y. C., Bahk, W.-M., & Yoon, B.-H. (2013). Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ. Neuropsychiatric Disease and Treatment, 9, 869–874. https://doi.org/10.2147/NDT.S39521
   PubMed Web of Science ®Google Scholar
• Brown, E. S., Nejtek, V. A., Perantie, D. C., & Bobadilla, L. (2002). Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disorders, 4(6), 406–411. https://doi.org/10.1034/j.1399-5618.2002.02229.x
   PubMed Web of Science ®Google Scholar
• Brown, E. S., Nejtek, V. A., Perantie, D. C., Orsulak, P. J., & Bobadilla, L. (2003). Lamotrigine in patients with bipolar disorder and cocaine dependence. The Journal of Clinical Psychiatry, 64(2), 197–201. https://doi.org/10.4088/JCP.v64n0213
   PubMed Web of Science ®Google Scholar
• Burns, L. (2014). World drug report 2013 by United Nations Office on Drugs and Crime New York: United Nations, 2013ISBN: 978-92-1-056168-6, 151 pp. Grey literature. Drug and Alcohol Review, 33(2), 216–216. https://doi.org/10.1111/dar.12110
   Web of Science ®Google Scholar
• Cerullo, M. A., & Strakowski, S. M. (2007). The prevalence and significance of substance use disorders in bipolar type I and II disorder. Substance Abuse Treatment, Prevention, and Policy, 2(1), 29. October 1). BioMed Central. https://doi.org/10.1186/1747-597X-2-29
   PubMedGoogle Scholar
• Chakrabarti, S., & Sinha, V. K. (2020). Dual diagnosis: Comorbid substance use disorder and mental illness. Indian Journal of Psychiatry, 62(Suppl 2), S214–S224. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_344_19
   Google Scholar
• Citrome, L., & Goldberg, J. F. (2005). The many faces of bipolar disorder. How to tell them apart. Postgraduate Medicine, 117(2), 15–23. https://doi.org/10.3810/pgm.2005.02.1583
   PubMed Web of Science ®Google Scholar
• Coles, A. S., Sasiadek, J., & George, T. P. (2019). Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review. Bipolar Disorders, 21(7), 595–610. https://doi.org/10.1111/bdi.12794
   PubMed Web of Science ®Google Scholar
• Fernández-Miranda, J. J., Fontoba-Díaz, J., Díaz-Fernández, S., & Pascual-Pastor, F. (2021). Co-occurrence of substance use disorders and other mental disorders in people undergoing specific treatment for any of them in Spain. Adicciones, 0(0), 1692. Advance online publication. https://doi.org/10.20882/adicciones.1692
   PubMedGoogle Scholar
• Frías, Á., Palma, C., & Farriols, N. (2015). Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment. Journal of Affective Disorders, 174, 378–389. https://doi.org/10.1016/j.jad.2014.12.008
   PubMed Web of Science ®Google Scholar
• Ghaemi, S. N., Ko, J. Y., & Goodwin, F. K. (2002). Cade’s disease’ and beyond: Misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 47(2), 125–134. Canadian Psychiatric Association. https://doi.org/10.1177/070674370204700202
   PubMed Web of Science ®Google Scholar
• Ghaemi, S. N., Hsu, D. J., Soldani, F., & Goodwin, F. K. (2003). Antidepressants in bipolar disorder: the case for caution. Bipolar disorders, 5(6), 421–433. https://doi.org/10.1046/j.1399-5618.2003.00074.x
   Google Scholar
• Ghaemi, S. N., Sachs, G. S., Chiou, A. M., Pandurangi, A. K., & Goodwin, F. K. (1999). Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? Journal of Affective Disorders, 52(1-3), 135–144. https://doi.org/10.1016/s0165-0327(98)00076-7
   PubMed Web of Science ®Google Scholar
• Gold, M. S., Pottash, A. C., Sweeney, D., Martin, D., & Extein, I. (1982). Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence. Annals of the New York Academy of Sciences, 398(1), 140–150. https://doi.org/10.1111/j.1749-6632.1982.tb39488.x
   PubMedGoogle Scholar
• Gold, A. K., Peters, A. T., Otto, M. W., Sylvia, L. G., Magalhaes, P. V. D. S., Berk, M., Dougherty, D. D., Miklowitz, D. J., Frank, E., Nierenberg, A. A., & Deckersbach, T. (2018). The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial. The Australian and New Zealand Journal of Psychiatry, 52(9), 847–855. https://doi.org/10.1177/0004867418788172
   PubMed Web of Science ®Google Scholar
• Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816. https://doi.org/10.1001/archpsyc.61.8.807
   PubMed Web of Science ®Google Scholar
• Grover, S., Chakrabarti, S., & Sahoo, S. (2020). Prevalence and clinical correlates of residual symptoms in remitted patients with bipolar disorder: An exploratory study. Indian Journal of Psychiatry, 62(3), 295–305. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_760_19
   PubMed Web of Science ®Google Scholar
• Harrison, P. J., Geddes, J. R., & Tunbridge, E. M. (2018). The emerging neurobiology of bipolar disorder. Trends in Neurosciences, 41(1), 18–30. https://doi.org/10.1016/j.tins.2017.10.006
   PubMed Web of Science ®Google Scholar
• Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry, 62(10), 1097–1106. https://doi.org/10.1001/archpsyc.62.10.1097
   PubMed Web of Science ®Google Scholar
• Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018). Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry, 75(4), 336–346. https://doi.org/10.1001/jamapsychiatry.2017.4602
   PubMed Web of Science ®Google Scholar
• Hayes, C. J., Krebs, E. E., Hudson, T., Brown, J., Li, C., & Martin, B. C. (2020). Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction (Abingdon, England), 115(6), 1098–1112. https://doi.org/10.1111/add.14940
   PubMed Web of Science ®Google Scholar
• Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., Russell, J. M., Sachs, G. S., & Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The mood disorder questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875. https://doi.org/10.1176/appi.ajp.157.11.1873
   PubMed Web of Science ®Google Scholar
• Hulvershorn, L. A., King, J., Monahan, P. O., Wilcox, H. C., Mitchell, P. B., Fullerton, J. M., Edenberg, H. J., Roberts, G. M. P., Kamali, M., Glowinski, A. L., Ghaziuddin, N., McInnis, M., Iyer-Eimerbrink, P. A., & Nurnberger, J. I. Jr (2017). Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk? Comprehensive Psychiatry, 78, 130–139. https://doi.org/10.1016/j.comppsych.2017.07.010
   PubMed Web of Science ®Google Scholar
• Hunt, G. E., Malhi, G. S., Cleary, M., Lai, H. M., & Sitharthan, T. (2016). Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis. Journal of Affective Disorders, 206, 331–349. https://doi.org/10.1016/j.jad.2016.07.011
   PubMed Web of Science ®Google Scholar
• Judd, L. L., & Akiskal, H. S. (2003). The prevalence and disability of bipolar spectrum disorders in the US population: Re-analysis of the ECA database taking into account subthreshold cases. Journal of Affective Disorders, 73(1-2), 123–131. https://doi.org/10.1016/S0165-0327(02)00332-4
   PubMed Web of Science ®Google Scholar
• Kvitland, L. R., Melle, I., Aminoff, S. R., Lagerberg, T. V., Andreassen, O. A., & Ringen, P. A. (2016). Cannabis use in first-treatment bipolar I disorder: relations to clinical characteristics. Early Intervention in Psychiatry, 10(1), 36–44. https://doi.org/10.1111/eip.12138
   PubMed Web of Science ®Google Scholar
• Kelly, T. (2018). Prospective: Is bipolar disorder being overdiagnosed? International Journal of Methods in Psychiatric Research, 27(3), e1725. https://doi.org/10.1002/mpr.1725
   PubMed Web of Science ®Google Scholar
• Khalili, N., & Gudarzi, S. S. (2012). Opioid withdrawal-induced hypomania: A case series. Journal of Opioid Management, 8(1), 67–72. https://doi.org/10.5055/jom.2012.0099
   PubMedGoogle Scholar
• Luciano, M., Steardo, L., Jr, Sampogna, G., Caivano, V., Ciampi, C., Del Vecchio, V., Di Cerbo, A., Giallonardo, V., Zinno, F., De Fazio, P., & Fiorillo, A. (2021). Affective Temperaments and Illness Severity in Patients with Bipolar Disorder. Medicina (Kaunas, Lithuania), 57(1), 54. https://doi.org/10.3390/medicina57010054
   PubMed Web of Science ®Google Scholar
• Maremmani, I., Maremmani, A. G., Rugani, F., Rovai, L., Pacini, M., Bacciardi, S., Deltito, J., Dell’Osso, L., & Akiskal, H. S. (2012). Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry. Annals of General Psychiatry, 11(1), 23. https://doi.org/10.1186/1744-859X-11-23
   PubMedGoogle Scholar
• McElroy, S. L., Altshuler, L. L., Suppes, T., Keck, P. E., Frye, M. A., Denicoff, K. D., Nolen, W. A., Kupka, R. W., Leverich, G. S., Rochussen, J. R., Rush, A. J., & Post, R. M. (2001). Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. The American Journal of Psychiatry, 158(3), 420–426. https://doi.org/10.1176/appi.ajp.158.3.420
   PubMed Web of Science ®Google Scholar
• Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry, 64(5), 543–552. https://doi.org/10.1001/ARCHPSYC.64.5.543
   PubMed Web of Science ®Google Scholar
• Obadeji, A., Oluwole, L. O., Kumolalo, B. F., & Dada, M. U. (2022). Patterns of Substance Use Disorders and Associated Co-occurring Psychiatric Morbidity among Patients Seen at the Psychiatric Unit of a Tertiary Health Center. Addiction & Health, 14(1), 35–43. https://doi.org/10.22122/ahj.v14i1.1275
   PubMedGoogle Scholar
• Oliva, V., De Prisco, M., Pons-Cabrera, M. T., Guzmán, P., Anmella, G., Hidalgo-Mazzei, D., Grande, I., Fanelli, G., Fabbri, C., Serretti, A., Fornaro, M., Iasevoli, F., de Bartolomeis, A., Murru, A., Vieta, E., & Fico, G. (2022). Machine learning prediction of comorbid substance use disorders among people with bipolar disorder. Journal of Clinical Medicine, 11(14), 3935. https://doi.org/10.3390/jcm11143935
   PubMed Web of Science ®Google Scholar
• Preuss, U. W., Schaefer, M., Born, C., & Grunze, H. (2021). Bipolar disorder and comorbid use of illicit substances. Medicina (Kaunas, Lithuania), 57(11), 1256. https://doi.org/10.3390/medicina57111256
   PubMed Web of Science ®Google Scholar
• Robins, E., & Guze, S. B. (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. The American Journal of Psychiatry, 126(7), 983–987. https://doi.org/10.1176/ajp.126.7.983
   PubMed Web of Science ®Google Scholar
• Salloum, I. M., & Thase, M. E. (2000). Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disorders, 2(3 Pt 2), 269–280. Blackwell Munksgaard. https://doi.org/10.1034/j.1399-5618.2000.20308.x
   PubMed Web of Science ®Google Scholar
• Samimiardestani, S. M., Gudarzi, S. S., Shahriari, N., Ramezani, F., & Foroughi, M. (2014). Patterns of substance abuse among Iranian bipolar inpatients: a descriptive research on existing data. International Journal of Applied Behavioral Sciences, 1(1), 38–44. https://doi.org/10.22037/ijabs.v1i1.7251
   Google Scholar
• Sayyah, M., Delirrooyfard, A., & Rahim, F. (2022). Assessment of the diagnostic performance of two new tools versus routine screening instruments for bipolar disorder: a meta-analysis. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999)), 44(3), 349–361. https://doi.org/10.1590/1516-4446-2021-2334
   PubMedGoogle Scholar
• Sesso, G., Brancati, G. E., & Masi, G. (2023). Comorbidities in youth with bipolar disorder: clinical features and pharmacological management. Current Neuropharmacology, 21(4), 911–934. https://doi.org/10.2174/1570159X20666220706104117
   PubMed Web of Science ®Google Scholar
• Sharma, V., Khan, M., & Smith, A. (2005). A closer look at treatment resistant depression: Is it due to a bipolar diathesis? Journal of Affective Disorders, 84(2-3), 251–257. https://doi.org/10.1016/j.jad.2004.01.015
   PubMed Web of Science ®Google Scholar
• Spoorthy, M. S., Chakrabarti, S., & Grover, S. (2019). Comorbidity of bipolar and anxiety disorders: An overview of trends in research. World Journal of Psychiatry, 9(1), 7–29. https://doi.org/10.5498/wjp.v9.i1.7
   PubMed Web of Science ®Google Scholar
• Teter, C. J., Falone, A. E., Bakaian, A. M., Tu, C., Ongür, D., & Weiss, R. D. (2011). Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Research, 190(2-3), 253–258. https://doi.org/10.1016/j.psychres.2011.05.042
   PubMed Web of Science ®Google Scholar
• Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005). Efficacy of antidepressants in substance use disorders with and without comorbid depression: A systematic review and meta-analysis. Drug and Alcohol Dependence, 78(1), 1–22. April 4). Elsevier Ireland Ltd. https://doi.org/10.1016/j.drugalcdep.2004.09.004
   PubMed Web of Science ®Google Scholar
• Wang, H. R., Bahk, W.-M., Yoon, B.-H., Kim, M.-D., Jung, Y.-E., Min, K. J., Hong, J., & Woo, Y. S. (2020). The influence of current mood states on screening accuracy of the mood disorder questionnaire. Clinical Psychopharmacology and Neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology, 18(1), 25–31. https://doi.org/10.9758/cpn.2020.18.1.25
   PubMed Web of Science ®Google Scholar
• Wenze, S. J., Gaudiano, B. A., Weinstock, L. M., Tezanos, K. M., & Miller, I. W. (2015). Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial. Psychiatry Research, 228(3), 516–525. https://doi.org/10.1016/j.psychres.2015.06.005
   PubMed Web of Science ®Google Scholar
• Ziaaddini, H., Ziaaddini, T., & Nakhaee, N. (2013). Pattern and trend of substance abuse in eastern rural iran: a household survey in a rural community. Journal of Addiction, 2013, 297378–6. https://doi.org/10.1155/2013/297378
   PubMedGoogle Scholar
• Zimmerman, M., Galione, J. N., Chelminski, I., Young, D., & Dalrymple, K. (2008). Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder. Psychiatry Research, 161(2), 166–172. https://doi.org/10.1111/j.1399-5618.2009.00755.x
   Google Scholar